Evidence map›Paper›PMID 42392258›Full record

ArticleMetabolism: clinical and experimental2026

Ablation of microglial estrogen receptor alpha predisposes male mice to diet-induced obesity.

Inmaculada Velasco, Jeremy M Frey, Vladislav Baglaev, Tristan Jafari, Thomas Huang, Sophia Schwie, Olivia D Santiago, Rachael D Fasnacht, Joshua P Thaler, Mauricio D Dorfman

Abstract read
In one paragraph

Article in Metabolism: clinical and experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Inmaculada VelascoUW Medicine Diabetes Institute, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA, 98109, USA.
Jeremy M FreyUW Medicine Diabetes Institute, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA, 98109, USA.
Vladislav BaglaevUW Medicine Diabetes Institute, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA, 98109, USA.
Tristan JafariUW Medicine Diabetes Institute, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA, 98109, USA.
Thomas HuangUW Medicine Diabetes Institute, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA, 98109, USA.
Sophia SchwieUW Medicine Diabetes Institute, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA, 98109, USA.
Olivia D SantiagoUW Medicine Diabetes Institute, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA, 98109, USA.
Rachael D FasnachtUW Medicine Diabetes Institute, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA, 98109, USA.
Joshua P ThalerUW Medicine Diabetes Institute, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA, 98109, USA.
Mauricio D DorfmanUW Medicine Diabetes Institute, Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA, 98109, USA. Electronic address: dorfmanm@uw.edu.

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI Ellen A Schur · 1986 to 2026
$30.4M
Metabolic Regulation by Microglial Inflammatory SignalingR01DK119754 · NIDDK · UNIVERSITY OF WASHINGTON · PI JOSHUA P THALER · 2018 to 2026
$5.1M
Sable Systems Promethion Core systemS10OD036208 · OD · UNIVERSITY OF WASHINGTON · PI MORTON, GREGORY J · 2024 to 2024
$898k
Role of estrogens in hypothalamic inflammation and metabolic regulation.R21DK127296 · NIDDK · UNIVERSITY OF WASHINGTON · PI DORFMAN, MAURICIO D · 2021 to 2023
$662k
Central regulation of atherosclerosis by testosterone-deficiencyK01HL153205 · NHLBI · UNIVERSITY OF WASHINGTON · PI DORFMAN, MAURICIO D · 2021 to 2024
$648k
NHLBI NIH HHS K01 HL153205NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK035816NIDDK NIH HHS R01 DK119754NIDDK NIH HHS R21 DK127296NIH HHS S10 OD036208
6 · The paper itself

Abstract

Estrogen receptor alpha (ERα) signaling has metabolic and anti-inflammatory properties in addition to its impact on reproductive function. Compared to females, male mice generally exhibit greater inflammatory activation of microglia and increased susceptibility to diet-induced obesity (DIO). Given the established metabolic protective effects of estrogen, these observations raise the possibility that sex differences in microglial estrogen signaling contribute to this sexual dimorphism. In this study, we assessed metabolic and CNS histopathological properties in a mouse model with inducible microglia-specific ablation of ERα (MG-ERαKO). Male MG-ERαKO mice developed increased weight gain and insulin resistance relative to controls during high-fat diet (HFD) feeding. Indirect calorimetry and food intake analysis revealed that reduced energy expenditure, coupled with an inadequate compensatory reduction in food intake, was the primary driver of the obese phenotype. In contrast, female MG-ERαKO mice fed HFD developed mild insulin resistance, with no change in body weight gain compared to controls, despite a similar reduction in energy expenditure. Immunohistochemical analyses of the microglial activation marker IBA1 in the mediobasal hypothalamus (MBH) revealed that female MG-ERαKO mice had an increased number of microglia without showing morphological signs of activation. In contrast, MBH microglial number was unchanged in MG-ERαKO male mice, but the cells adopted more activated morphological profiles. Finally, HFD-fed MG-ERαKO male mice had increased POMC neuron-microglia interactions but fewer overall hypothalamic POMC neurons, suggesting microglia may disrupt POMC neuron integrity to promote DIO. Together, these findings indicate that sex-specific actions of estrogen in microglia limit the metabolic complications of HFD feeding.

Indexed as

Diet, High-FatEstrogen Receptor alphaMicrogliaObesityAnimalsEatingEnergy MetabolismFemaleHypothalamusInsulin ResistanceMaleMiceMice, Inbred C57BLMice, KnockoutWeight GainEsr1 protein, mouseEstrogen Receptor alphaEstrogen receptor alphaMicrogliaNeuroinflammationObesityPOMC neurons

Identifiers

PMID42392258
PMCPMC13394830

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.